Head and Neck Cancer News and Research

RSS

Head and Neck Cancer is cancer that arises in the head or neck region (in the nasal cavity, sinuses, lips, mouth, salivary glands, throat, or larynx [voice box]).

Navidea announces FDA extension of Lymphoseek PDUFA date by three months

Navidea Biopharmaceuticals, Inc. today announced that yesterday it received notification from the United States Food and Drug Administration (FDA) that the Prescription Drug User Fee Act (PDUFA) date for 99m-Tc-Tilmanocept, has been modified to September 10, 2012, a 90-day extension from the initial PDUFA date of June 10th.

4 Apr 2012

CYP1B1 protein may be a potential target for intervention in head and neck cancer

Squamous cell carcinoma of the head and neck-which typically arises from thin, flat cells that line moist surfaces inside the mouth, nose and throat-is the sixth most common type of cancer worldwide, and it has a relatively low five-year survival rate and a high recurrence rate.

2 Apr 2012

Clinical data for cabozantinib to be presented at ASCO annual meeting

Exelixis, Inc. announced today that its lead compound, cabozantinib, will be the subject of nine separate data presentations at the upcoming Annual Meeting of the American Society of Clinical Oncology.

2 Apr 2012

RT3D may boost effects of two standard chemotherapy drugs in head and neck cancer patients

A naturally-occurring harmless human virus may be able to boost the effects of two standard chemotherapy drugs in some cancer patients, according to early stage trial data published today in Clinical Cancer Research.

2 Apr 2012

Aurora-A protein plays an important role in head and neck cancer

Researchers at Fox Chase Cancer Center in Philadelphia have found that a protein associated with other cancers appears to also be important in head and neck cancer, and may consequently serve as a good target for new treatments. The findings will be reported at the AACR Annual Meeting 2012 on Sunday, April 1.

2 Apr 2012

HPV-related head and neck cancer on the rise among middle-aged white men

Research led by Lauren Cole, a public health graduate student, and Dr. Edward Peters, Associate Professor of Public Health and Director of the Epidemiology Program at LSU Health Sciences Center New Orleans, reports that the incidence of head and neck cancer has risen at sites associated with Human Papilloma Virus (HPV) infection, with the greatest increase among middle-aged white men.

30 Mar 2012

OncoSec to present data from head and neck cancer studies at two upcoming conferences

OncoSec Medical Incorporated., which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumor cancers, today announced that the company has been selected to present data from its Phase III and IV head and neck cancer studies at two upcoming conferences.

23 Mar 2012

U.S. to launch graphic anti-smoking warnings

The United States Government is starting a major new effort to cut the country's smoking rate by showing graphic images of people who have sustained life-altering health problems after smoking for years.

18 Mar 2012

Sosei initiates SO-1105 Phase I trial in oropharyngeal candidiasis

Sosei Group Corporation, the biopharmaceutical company, today announces that its wholly owned Japanese subsidiary, Sosei Co., Ltd., has initiated a Japanese Phase I trial for SO-1105 for the treatment of oropharyngeal candidiasis.

8 Mar 2012

Inovio's SynCon vaccine for HPV types 6 and 11 induces CD8+ T cells in mice

Inovio Pharmaceuticals, Inc. announced today that its SynCon therapeutic vaccine for human papillomavirus (HPV) types 6 and 11, which are associated with head & neck cancers and genital warts, among other conditions, induced strong antigen-specific CD8+ T cells in mice.

5 Mar 2012

Proceeds from Polo Under the Palms in Sarasota to benefit MD Anderson Cancer Center

Polo mallets and palm trees take center stage as Polo Under the Palms returns to Sarasota, Fla., March 24. Proceeds from the second annual competition benefit The University of Texas MD Anderson Cancer Center.

2 Mar 2012

Researchers test nanoscale carbon clusters for cancer chemotherapy

A mixture of current drugs and carbon nanoparticles shows potential to enhance treatment for head-and-neck cancers, especially when combined with radiation therapy, according to new research by Rice University and the University of Texas MD Anderson Cancer Center.

16 Feb 2012

Adaptive radiotherapy may benefit patients with head and neck cancer

Researchers led by a senior investigator at Hofstra-North Shore LIJ School of Medicine and The Feinstein Institute for Medical Research have released initial findings from a first-of-a-kind clinical trial in adaptive radiotherapy (ART) for head and neck cancer.

10 Feb 2012

MD Anderson study defines value in health care

A team from The University of Texas MD Anderson Cancer Center is receiving a national award for a research article tackling a question vital to the future of health care with reform regulations looming, competition growing and costs rising.

3 Feb 2012

Oral HPV infection more common in men than women: Study

According to a new US study, oral human papillomavirus (HPV) infection is more common among men than women, leading to an increased risk for men of head and neck cancers. HPV causes the majority of cervical cancers, as well as genital and anal - and head and neck cancers.

31 Jan 2012

Non-smoking, non-drinking transplant patients more likely to develop head and neck cancer

Transplant patients who develop head and neck cancer are more likely to be non-smokers and non-drinkers, and less likely than their non-transplant counterparts to survive past one year of diagnosis, according to a new study from Henry Ford Hospital in Detroit.

30 Jan 2012

HPV transmission via oral sex practices suggests research

A new study suggested that an estimated 7% of American teens and adults carry the human papillomavirus in their mouths. This may help health experts finally understand why rates of mouth and throat cancer have been climbing for nearly 25 years. The evidence additionally makes it clear that oral sex practices play a key role in transmission.

29 Jan 2012

Study shows grape seed extract kills head and neck squamous cell carcinoma cells

Nearly 12,000 people will die of head and neck cancer in the United States this year and worldwide cases will exceed half a million.

27 Jan 2012

Prevalence of oral HPV infection more common among men: Study

Oral HPV infection is more common among men than women, explaining why men are more prone than women to develop an HPV related head and neck cancer, according to a study presented at the Multidisciplinary Head and Neck Cancer Symposium, sponsored by AHNS, ASCO, ASTRO and SNM.

27 Jan 2012

Positive results from cisplatin plus radiation therapy trial on head and neck cancer

A select subgroup of advanced head and neck cancer patients treated with radiation therapy plus the chemotherapy drug cisplatin had more positive outcomes than patients treated with radiation therapy alone and continued to show positive results 10 years post-treatment, according to a study presented at the Multidisciplinary Head and Neck Cancer Symposium, sponsored by AHNS, ASCO, ASTRO and SNM.

27 Jan 2012

Head and Neck Cancer News and Research

Navidea announces FDA extension of Lymphoseek PDUFA date by three months

CYP1B1 protein may be a potential target for intervention in head and neck cancer

Clinical data for cabozantinib to be presented at ASCO annual meeting

RT3D may boost effects of two standard chemotherapy drugs in head and neck cancer patients

Aurora-A protein plays an important role in head and neck cancer

HPV-related head and neck cancer on the rise among middle-aged white men

OncoSec to present data from head and neck cancer studies at two upcoming conferences

U.S. to launch graphic anti-smoking warnings

Sosei initiates SO-1105 Phase I trial in oropharyngeal candidiasis

Inovio's SynCon vaccine for HPV types 6 and 11 induces CD8+ T cells in mice

Proceeds from Polo Under the Palms in Sarasota to benefit MD Anderson Cancer Center

Researchers test nanoscale carbon clusters for cancer chemotherapy

Adaptive radiotherapy may benefit patients with head and neck cancer

MD Anderson study defines value in health care

Oral HPV infection more common in men than women: Study

Non-smoking, non-drinking transplant patients more likely to develop head and neck cancer

HPV transmission via oral sex practices suggests research

Study shows grape seed extract kills head and neck squamous cell carcinoma cells

Prevalence of oral HPV infection more common among men: Study

Positive results from cisplatin plus radiation therapy trial on head and neck cancer

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News